Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Elderly, National Institutes of Health, Paxlovid (Drug), Pfizer Inc, Research, United States
←WATCH: In My Feed – Celebrity Breakups In 2023 That Shocked Us All
WATCH: In My Feed – Films To Watch This Year→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube